strontium (2PX) / SantoSolve 
Welcome,         Profile    Billing    Logout  
 3 Diseases   1 Trial   1 Trial   0 News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
strontium (2PX) / SantoSolve
2005-004254-26: A double-blind, placebo-controlled, enriched enrolment, randomized-withdrawal study to evaluate the efficacy and safety of 2PX in patients with pain due to osteoarthritis of the knee

Ongoing
2
60
Europe
2PX, 2PX,
Santosolve A/S
Patients with osteoarthritis of the knee
 
 

Download Options